ACAnne-Marie De Cock

Anne-Marie De Cock

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne-Marie De Cock has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rethinking sarcopenia: a conceptual shift towards a muscle health continuum

    by Stany Perkisas, Kristoffer K. Brockhattingen, Ester López Jiménez, Michael O. Harris-Love, Sophie Bastijns, Anne-Marie De Cock, Femke Ariën, Chun Yuen Johnny Chung, Lynn Longueville, Karen Andersen-Ranberg, et al.

    Purpose Current guideline-based approaches to sarcopenia are operationalised around thresholds of muscle mass, strength, and performance, which limit the opportunities for early/preventive intervention. This view insufficiently reflects skeletal muscle as a multifunctional organ and fails to capture its dynamic and heterogeneous nature. The objective of this manuscript is to place sarcopenia within this muscle health continuum. Methods Expert discussions were conducted to identify conceptual limitations in existing approaches and to explore opportunities for improvement. These discussions were complemented by a narrative review of the literature, forming an integrative conceptual framework. Results A six-stage muscle health continuum is proposed in which sarcopenia is positioned as an advanced, pathological state rather than a binary diagnosis. Conceptual definitions of muscle health and muscle failure are introduced, alongside causal factors as potential targets for treatment as well as an aetiological stratification into subtypes. The framework is aligned with the International Classification of Functioning, Disability and Health to contextualise muscle dysfunction in terms of functioning and disability. To enhance diagnostic resolution and treatment monitoring, the concept of muscle profile analysis is introduced, supporting the use of direct muscle visualisation techniques such as ultrasound, computed tomography, and magnetic resonance imaging. Conclusion Positioning sarcopenia within a broader muscle health continuum reframes it from a late-stage geriatric diagnosis into a condition embedded within a lifelong trajectory. This conceptual shift hopes to kindle discussions about earlier assessment, preventive strategies, and individualised interventions, laying the foundation for future research, clinical innovation, and guideline evolution aimed at improving patient outcomes.


  • Nurses' responses to patients' medication self‐management problems in hospital and the use of recommendations

    by Laura Mortelmans, Eva Goossens, Anne‐Marie De Cock, Patricia van Den Bemt, Tinne Dilles

    This study aimed to describe the use of recommendations as a guide for healthcare providers to support patients experiencing medication self‐management problems and to evaluate their feasibility, user‐friendliness and usefulness. Between March and August 2023, 58 hospitalized patients completed a self‐assessment on medication self‐management problems. The problems addressed in this self‐assessment were based on a list of frequently encountered medication self‐management problems from previous research. Consequently, 18 nurses responded to the reported problems using the recommendations. Nurses evaluated the feasibility, user‐friendliness and usefulness of these recommendations through a survey. A total of 217 medication self‐management problems were reported by 58 patients. Nurses intervened in 52% of the problems using the recommendations. According to nurses, the recommendations were user‐friendly and feasible but required a substantial time investment. Considering these pilot‐based results, the recommendations have the potential to be a valuable resource for nurses in practice, though this potential requires further exploration.


  • Evaluation of methods measuring medication adherence in patients with polypharmacy: a longitudinal and patient perspective

    by Laura Mortelmans, Eva Goossens, Marjan De Graef, Jana Van Dingenen, Anne-Marie De Cock, Mirko Petrovic, Patricia van Den Bemt, Tinne Dilles

    Purpose To explore patients’ willingness to have medication adherence measured using different methods and evaluate the feasibility and validity of their combination (i.e., pill counts, a medication diary and a questionnaire assessing adherence two months post-discharge). Methods (1) A cross-sectional evaluation of the willingness of patients with polypharmacy to have their medication adherence measured post-discharge. (2) Medication adherence was monitored during two months using pill counts based on preserved medication packages and a diary in which patients registered their adherence-related problems. During a home visit, the Probabilistic Medication Adherence Scale (ProMAS) and a questionnaire on feasibility were administered. Results A total of 144 participants completed the questionnaire at discharge. The majority was willing to communicate truthfully about their adherence (97%) and to share adherence-related information with healthcare providers (99%). More participants were willing to preserve medication packages (76%) than to complete a medication diary (67%) during two months. Most participants reported that preserving medication packages (91%), completing the diary (99%) and the ProMAS (99%) were no effort to them. According to the majority of participants (60%), pill counts most accurately reflected medication adherence, followed by the diary (39%) and ProMAS (1%). Medication adherence measured by pill counts correlated significantly with ProMAS scores, but not with the number of diary-reported problems. However, adherence measured by the medication diary and ProMAS correlated significantly. Conclusion Combining tools for measuring adherence seems feasible and can provide insight into the accordance of patients’ actual medication use with their prescribed regimen, but also into problems contributing to non-adherence.


  • Open Access

    The Development of Recommendations for Healthcare Providers to Support Patients Experiencing Medication Self-Management Problems

    by Laura Mortelmans, Eva Goossens, Anne-Marie De Cock, Mirko Petrovic, Patricia van Den Bemt, Tinne Dilles

    Medication self-management problems such as the inability to correctly obtain, understand, organize, administer or monitor medication can result in negative patient outcomes. However, supportive tools for healthcare providers to assist patients with medication self-management problems are lacking. This study aimed to develop recommendations for healthcare providers to support patients with polypharmacy who experience medication self-management problems. A three-phase study was conducted starting with (1) the mapping of medication self-management problems, followed by (2) a scoping review providing a list of relevant interventions and actions for each respective problem and (3) a three-round modified e-Delphi study with experts to reach consensus on the relevance and clarity of the recommended interventions and actions. The cut-off for consensus on the relevance and clarity of the recommendations was set at 80% expert agreement. Experts could propose additional recommendations based on their professional experience and expertise. The experts (n = 23) involved were healthcare professionals (i.e., nurses, pharmacists, and physicians) with specific expertise in medication management of patients with polypharmacy. Simultaneous with the second e-Delphi round, a panel of patients with polypharmacy (n = 8) evaluated the usefulness of recommendations. Results obtained from the patient panel were fed back to the panel of healthcare providers in the third e-Delphi round. Descriptive statistics were used for data analysis. Twenty medication self-management problems were identified. Based on the scoping review, a list of 66 recommendations for healthcare providers to support patients with the identified medication self-management problems was composed. At the end of the three-round e-Delphi study, the expert panel reached consensus on the relevance and clarity of 67 recommendations, clustered according to the six phases of the medication self-management model by Bailey et al. In conclusion, this study resulted in a guidance document including recommendations that can serve as a resource for healthcare providers to support patients with polypharmacy in case of medication self-management problems. Future research should focus on the evaluation of the feasibility and user-friendliness of the guide with recommendations in clinical practice.


  • Open Access

    Investigating sarcopenia awareness using Google Trends

    by Sandrine Gilliot, Sophie Bastijns, Stany Perkisas, Anne-Marie De Cock

    Sarcopenia is reported as an important health issue. This study investigates with Google Trends whether the clinical importance of sarcopenia is reflected in public interest in the disease. The study was performed between January and March 2020. Data were collected using Google Trends (worldwide). The compared topics were dementia, frailty, polypharmacy, osteoporosis and sarcopenia. A comparison of the topics revealed that “dementia’’ displayed the highest relative search volume followed by “osteoporosis” and “frailty”. The relative search volume of ‘‘sarcopenia’’ was very low and the lowest relative search volume was contributed to “polypharmacy”. In conclusion, despite the growing interest in the clinical and research community, it is still a relatively unknown topic for the general public. Taking in account the preventive potential of interventions against sarcopenia, it is important to increase the awareness among lay people. In this set-up, Google Trends could be an important tool to evaluate public interest in geriatric topics. It could help to convince policy makers that there is need for awareness programs on sarcopenia.


  • Open Access

    Comprehensive Quantitative Spatiotemporal Gait Analysis Identifies Gait Characteristics for Early Dementia Subtyping in Community Dwelling Older Adults

    by Anne-Marie De Cock, Erik Fransen, Stany Perkisas, Veronique Verhoeven, Olivier Beauchet, Maurits Vandewoude, Roy Remmen

    Background: Recent studies associated gait patterns with cognitive impairment stages. The current study examined the relation between dementia type and spatiotemporal gait characteristics under different walking conditions in pre and mild neurocognitive disorder stage. Methods: Community-dwelling older adults (age 50+) with memory complaints consulting a memory clinic underwent, at baseline and during follow-up (every 4 months), a standard dementia assessment and a comprehensive spatiotemporal gait analysis [walking on an electronic walkway at usual pace (UP) with and without a counting-backwards (CW) or animal-reciting dual-task (AW), at fast (FP) and at slow (SP) pace]. At baseline the participants were categorized according to the Clinical Dementia Rating (CDR) scale. At the end of the study, the dementia diagnosis was used to stratify the categories in three outcome groups: developed “No-dementia,” “AD+FTD” (grouping Alzheimer's or Fronto-temporal dementia) or “VascD+LBD” dementia (grouping Vascular dementia or Lewy body dementia). The gait characteristics were compared per category in paired groups. Sub-analyzing in the ≥70-years-old participants evaluated the age effect. Results: Five hundred and thirty-six participants, age 50-to-95-years old were followed for 31-to-41 months. In the CDR 0, no differences were seen between eventual dementia and no-dementia individuals. In the CDR 0.5, CW dual task cost (DTC) step width was larger in the imminent “AD+FTD” and AW (normalized) gait speed was slower in the future “VascD+LBD” group compared to the no-dementia participants. Slower UP (normalized) gait speed differed the future “VascD+LBD” from the “AD+FTD” individuals. In the CDR 1: Wider steps in UP, SP and CW differed the “VascD+LBD” from the “AD+FTD” group. In the ≥70-years old CDR 0 category, higher AW cycle time variability in the imminent “AD+FTD” dementia group, wider UP step width and higher AW cycle time variability in the “VascD+LBD” group differed them from the no-dementia group up to 3 years before dementia diagnosis. The distinctive gait characteristics between the no-dementia and the imminent dementia groups in CDR 0.5 and CDR 1 remained the same as in the overall group. However, no gait differences were found between “VascD+LBD” and “AD+FTD” groups in the pre-dementia stages. Conclusion: Distinctive spatiotemporal gait characteristics were associated with specific dementia types up to 3 years before diagnosis. The association is influenced by the cognitive stage and age.


  • The impact of cognitive impairment on the physical ageing process

    by Anne-Marie De Cock, Stany Perkisas, Veronique Verhoeven, Maurits Vandewoude, Erik Fransen, Roy Remmen

    Physical decline and cognitive degeneration characterise the ageing process.


  • Open Access

    Gait characteristics under different walking conditions: Association with the presence of cognitive impairment in community-dwelling older people

    by Anne-Marie De Cock, Erik Fransen, Stany Perkisas, Veronique Verhoeven, Olivier Beauchet, Roy Remmen, Maurits Vandewoude

    Gait characteristics measured at usual pace may allow profiling in patients with cognitive problems. The influence of age, gender, leg length, modified speed or dual tasking is unclear. Cross-sectional analysis was performed on a data registry containing demographic, physical and spatial-temporal gait parameters recorded in five walking conditions with a GAITRite® electronic carpet in community-dwelling older persons with memory complaints. Four cognitive stages were studied: cognitively healthy individuals, mild cognitive impaired patients, mild dementia patients and advanced dementia patients. The association between spatial-temporal gait characteristics and cognitive stages was the most prominent: in the entire study population using gait speed, steps per meter (translation for mean step length), swing time variability, normalised gait speed (corrected for leg length) and normalised steps per meter at all five walking conditions; in the 50-to-70 years old participants applying step width at fast pace and steps per meter at usual pace; in the 70-to-80 years old persons using gait speed and normalised gait speed at usual pace, fast pace, animal walk and counting walk or steps per meter and normalised steps per meter at all five walking conditions; in over-80 years old participants using gait speed, normalised gait speed, steps per meter and normalised steps per meter at fast pace and animal dual-task walking. Multivariable logistic regression analysis adjusted for gender predicted in two compiled models the presence of dementia or cognitive impairment with acceptable accuracy in persons with memory complaints. Gait parameters in multiple walking conditions adjusted for age, gender and leg length showed a significant association with cognitive impairment. This study suggested that multifactorial gait analysis could be more informative than using gait analysis with only one test or one variable. Using this type of gait analysis in clinical practice could facilitate screening for cognitive impairment.


  • Open Access

    Intramuscular Adipose Tissue and the Functional Components of Sarcopenia in Hospitalized Geriatric Patients

    by Stany Perkisas, Anne-Marie De Cock, Veronique Verhoeven, Maurits Vandewoude

    Intramuscular adipose tissue (IMAT) could be an important missing value in the assessment of sarcopenia. This study tries to determine the relation between IMAT, muscle strength, functionality and mortality. In addition, the relation with nutritional status is screened. For six months, all patients admitted to the University Geriatric Center of Antwerp were evaluated for strength (hand grip), functionality (short physical performance battery—SPPB) and nutritional status. After one year, patients/relatives were contacted to obtain a current health status (mortality). A total of 303 patients were included at a mean age of 83.0 ± 6.4 years. The mean percentage of IMAT was 29.2% ± 13.0% (range 3.2%–86.2%). There was a negative correlation between IMAT and both grip strength and SPPB. SPPB was positively correlated with both grip strength and muscle mass. There was a positive correlation between IMAT and mortality. There was a negative correlation between grip strength, SPPB and mortality. IMAT did not have a clear relation with nutritional status. IMAT should be addressed in the work-up of sarcopenia, as it is correlated with muscle strength, functionality and mortality. In this cohort of hospitalized geriatric patients, there is a mean of about one-third of measured muscle volume that appears to be adipose tissue.